Evidence map›Paper›PMID 41307910›Full record

ArticleEuropean heart journal2025

Neutrophil extracellular traps and peptidylarginine deiminase 4-mediated inflammasome activation link diabetes to cardiorenal injury and heart failure.

Nicolas Schommer, Nicolas Gendron, Krystin Krauel, Stijn Van Bruggen, Pierre-André Jarrot, Alexander Maier, William Chan, Harald F Langer, Daniel Duerschmied, Dirk Westermann and 3 more

Abstract read
In one paragraph

Article in European heart journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. MMP8 Promotes NETosis in Gestational Diabetes Mellitus.Antioxidants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nicolas SchommerProgram in Cellular and Molecular Medicine, Boston Children's Hospital, 1 Blackfan Circle Boston, MA 02115, USA.ORCID 0000-0001-9568-9426
Nicolas GendronProgram in Cellular and Molecular Medicine, Boston Children's Hospital, 1 Blackfan Circle Boston, MA 02115, USA.ORCID 0000-0003-4852-4738
Krystin KrauelCardiology, Haemostaseology, and Medical Intensive Care, Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Stijn Van BruggenProgram in Cellular and Molecular Medicine, Boston Children's Hospital, 1 Blackfan Circle Boston, MA 02115, USA.ORCID 0000-0002-5572-2196
Pierre-André JarrotProgram in Cellular and Molecular Medicine, Boston Children's Hospital, 1 Blackfan Circle Boston, MA 02115, USA.ORCID 0000-0002-6469-9047
Alexander MaierDepartment of Cardiology and Angiology, University Hospital Freiburg Bad Krozingen, Hugstetterstrasse 55, 79106 Freiburg, Germany.ORCID 0000-0003-0200-7495
William ChanProgram in Cellular and Molecular Medicine, Boston Children's Hospital, 1 Blackfan Circle Boston, MA 02115, USA.
Harald F LangerCardiology, Haemostaseology, and Medical Intensive Care, Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0003-2224-0518
Daniel DuerschmiedCardiology, Haemostaseology, and Medical Intensive Care, Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Dirk WestermannDepartment of Cardiology and Angiology, University Hospital Freiburg Bad Krozingen, Hugstetterstrasse 55, 79106 Freiburg, Germany.ORCID 0000-0002-7542-1956
Karin KlingelCardiopathology, Institute for Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.ORCID 0000-0003-0203-2498
Denisa D WagnerProgram in Cellular and Molecular Medicine, Boston Children's Hospital, 1 Blackfan Circle Boston, MA 02115, USA.ORCID 0000-0002-4494-413X
Lukas A HegerProgram in Cellular and Molecular Medicine, Boston Children's Hospital, 1 Blackfan Circle Boston, MA 02115, USA.ORCID 0000-0002-9419-5675

Funding

How inflammation and thrombosis fuel disease and aging: Focus on NETsR35HL135765 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI WAGNER, DENISA D · 2017 to 2023
$6.2M
Inflammation and thrombosis fuel cardiovascular and pulmonary disease: Focus on the interplay of neutrophil inflammasomes with NETsR35HL166556 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI DENISA D WAGNER · 2023 to 2026
$4.9M
Berta-Ottenstein-ProgrammeCarl Zeiss FoundationElse-Kröhner Fresenius Stiftung 2023_EKSE.46German Research Centre for Cardiovascular Research 394046768German Research Centre for Cardiovascular Research FKZ81Z0700110German Research Foundation DFG HE 8679/1-1NHLBI NIH HHS NIH R35 HL135765NHLBI NIH HHS R35 HL135765NHLBI NIH HHS R35 HL166556Physician Scientist Program of the Helmholtz-Institute for Translational AngioCardioScience (HI-TAC)Society for Thrombosis and Haemostasis Research
6 · The paper itself

Abstract

BACKGROUND AND

aimsDiabetes is associated with increased risk of cardiovascular and renal disease. This study investigated the role of peptidylarginine deiminase 4 (PAD4), neutrophil extracellular traps (NETs), and inflammasome activation in diabetic cardiomyopathy (DCM) and kidney disease (DKD).

methodsEndomyocardial biopsies (EMB) from heart failure (HF) patients (n = 20) with or without diabetes were stained for NETs. Wild-type (WT) and PAD4⁻/⁻ mice were subjected to streptozotocin (STZ)-induced diabetes and cardiac function, blood glucose, body weight, and exercise tolerance were assessed longitudinally. NETosis and ASC specks were evaluated in mouse and human neutrophils. Cardiac and renal fibrosis was assessed by Sirius Red/Fast Green staining. Confocal microscopy, ELISA, and flow cytometry were used to quantify NETs, IL-1β, von Willebrand factor (VWF), cytokine transforming growth factor beta-1 (TGF-β1), and neutrophil infiltration.

resultsMyocardial NET burden was increased in HF patients with diabetes. High glucose triggered inflammasome activation in human neutrophils. After STZ, PAD4⁻/⁻ and WT mice developed hyperglycaemia and weight loss, yet only WT neutrophils showed increased NETosis and ASC speck formation. Only diabetic WT mice exhibited elevated IL-1β and VWF levels, impaired cardiac function, reduced exercise tolerance, and pulmonary oedema; PAD4⁻/⁻ mice were protected. Wild-type diabetic hearts and kidneys showed greater fibrosis, neutrophil infiltration, NETs, and TGF-β1 levels. Kidney injury in WT mice was reflected by albuminuria and renal fibrosis, whereas PAD4⁻/⁻ mice preserved renal function.

conclusionsDiabetes promotes neutrophil inflammasome activation and NETosis, driving cardiac and renal inflammation and fibrosis. Peptidylarginine deiminase 4 deficiency prevents heart failure and preserves kidney function in experimental diabetes.

Indexed as

Chronic kidney diseaseDiabetesHeart failureInflammasomeNeutrophil extracellular traps (NETs)PAD4

Identifiers

PMID41307910
PMCPMC12751317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.